Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00344136 · ClinicalTrials.gov registry record

Identifying Genes That May Increase the Risk for Heart Disease in African Americans

A clinical trial of Heart Diseases, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Completed
Registry status
5,302
Enrollment target
1
Study location

NCT00344136: Completed study of Heart Diseases, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

NCT00344136 is a study of Heart Diseases that has completed, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 5,302 participants, roughly in line with the 5,470-participant average among 85 other Heart Diseases trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00344136, a study of Heart Diseases, has completed, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

COMPLETED
Registry status
5,302 participants
Enrollment target
1
Study location

Study Summary

Heart disease and stroke disproportionately affect African Americans in the United States. These conditions are likely caused by both environmental and genetic factors. This study will attempt to identify specific genes of African and European ancestral origins that may influence the development of heart disease in African Americans.

Conditions Studied

Study Locations (1)

Mississippi

  • University of Mississippi School of Medicine - Jackson

Trial Details

FieldValue
Enrollment Target 5,302 participants
Start Date 2000-09
Est. Completion 2004-03

What the finished NCT00344136 record still lists

NCT00344136 is an observational study that tracks outcomes without assigning an intervention. Its 5,302 participants enrollment target places it among the larger protocols in the corpus, roughly in line with the 5,470-participant average among 85 other Heart Diseases trials with a reported enrollment target.

The record links to 1 condition, with Heart Diseases appearing as the primary indexed condition, and to 0 interventions.

NCT00344136 reports a single indexed study location in Mississippi.

Frequently Asked Questions

What is clinical trial NCT00344136 about?

NCT00344136 is a clinical study titled "Identifying Genes That May Increase the Risk for Heart Disease in African Americans". Heart disease and stroke disproportionately affect African Americans in the United States. These conditions are likely caused by both environmental and genetic factors. This study will attempt to identify specific genes of African and European ancestral origins that may influence the development of ...

What is the current status of trial NCT00344136?

This trial is currently completed. The enrollment target is 5,302 participants. The study started on 2000-09. Estimated completion is 2004-03.

What conditions does trial NCT00344136 study?

This clinical trial studies the following conditions: Heart Diseases.

Who is sponsoring clinical trial NCT00344136?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00344136 being conducted?

This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Heart Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00344136's enrollment target sits among peer trials

5,302 10th of 85 higher than 76 of 85 other Heart Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Heart Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT05373771 · 5,328 participants · NA

    Sickle Cell Improvement: Enhancing Care in the Emergency Department

  • NCT05836987 · 5,350 participants · Phase 3

    The Rhythm Evaluation for AntiCoagulaTion With Continuous Monitoring of Atrial Fibrillation

  • NCT06506344 · 5,250 participants · NA

    Syncing Screening and Services for Suicide Prevention Across Health and Justice Systems

  • NCT05989308 · 5,200 participants · NA

    MyChart Proxy Outreach to Parents (MyPOP)

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00344136, the US trial registry maintained by the National Library of Medicine. NCT00344136 (large enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.